118 related articles for article (PubMed ID: 8698137)
1. Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopenia.
Bruserud O; Aasen I; Akselsen PE; Bergheim J; Rasmussen G; Nesthus I
Eur J Haematol; 1996 Jul; 57(1):87-95. PubMed ID: 8698137
[TBL] [Abstract][Full Text] [Related]
2. Effects of endogenous interleukin 1 on blast cells derived from acute myelogenous leukemia patients.
Bruserud O
Leuk Res; 1996 Jan; 20(1):65-73. PubMed ID: 8632679
[TBL] [Abstract][Full Text] [Related]
3. Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro.
Bruserud O; Nesthus I; Bühring HJ; Pawelec G
Leuk Res; 1995 Jan; 19(1):15-22. PubMed ID: 7530789
[TBL] [Abstract][Full Text] [Related]
4. Effects of hematopoietic growth factors on interleukin 6 secretion by blast cells derived from acute myelogenous leukemia patients.
Bruserud O; Mentzoni L; Bühring HJ; Pawelec G
Acta Haematol; 1996; 96(3):155-61. PubMed ID: 8876613
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
6. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
Bruserud O
Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
[TBL] [Abstract][Full Text] [Related]
9. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
Carter A; Silvian-Draxler I; Tatarsky I
Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
[TBL] [Abstract][Full Text] [Related]
10. Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells.
Carter A; Haddad N; Draxler I; Israeli E; Raz B; Rowe JM
Br J Haematol; 1996 Jan; 92(1):116-26. PubMed ID: 8562381
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
12. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
14. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud O
Eur J Haematol; 2001 Jun; 66(6):365-76. PubMed ID: 11488935
[TBL] [Abstract][Full Text] [Related]
16. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
17. Growth regulation of the AML-193 leukemic cell line: evidence for autocrine production of granulocyte-macrophage colony-stimulating factor (GM-CSF), and inhibition of GM-CSF-dependent cell proliferation by interleukin-1 (IL-1) and tumor necrosis factor (TNF alpha).
Kindler V; Shields J; Ayer D; Mazzei GJ
Int J Cancer; 1991 Feb; 47(3):450-4. PubMed ID: 1993554
[TBL] [Abstract][Full Text] [Related]
18. Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
Salem M; Delwel R; Touw I; Mahmoud LA; Elbasousy EM; Löwenberg B
Leukemia; 1990 Jan; 4(1):37-43. PubMed ID: 1688638
[TBL] [Abstract][Full Text] [Related]
19. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.
Narita M; Takahashi M; Liu A; Nikkuni K; Furukawa T; Toba K; Koyama S; Takai K; Sanada M; Aizawa Y
Exp Hematol; 2001 Jun; 29(6):709-19. PubMed ID: 11378266
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
